Communications regarding the safety of medicines

HPC / DHPC / Out-of-Stock

Batch recalls human medicines

Batch recall – Rapifen, Injektionslösung

Die Firma Janssen-Cilag AG zieht alle Chargen mit Verfalldatum 05.2021 oder früher von Rapifen, Injektionslösung aufgrund fehlerhafter Darstellung der Tabelle zur Dosisbestimmung der initialen i.v. Bolus-Injektion in der Packungsbeilage vom Markt zurück.

Communications regarding the safety of medical devices

Swissmedic – for therapeutic products you can trust

We are the Swiss agency for the authorisation and supervision of therapeutic products (medicinal products and medical devices). We fulfil our legal mandate and work with partner authorities on a national and international basis.

We endeavour to ensure that authorised therapeutic products are of high quality, effective and safe.

 

By doing so, we make a considerable contribution towards protecting the health of humans and animals, and we also participate in safeguarding Switzerland as a location for industry and research.

Other announcements

Swissmedic Portal

The Swissmedic eGovernment Portal provides the basic IT components for current and future eGov processes and services. Further information...

 

eGov services application form

Login to the Swissmedic Portal

Support/questions about eGov services

Selected Topics

Penal Law

Swissmedic is mandated to carry out a considerable proportion of the penal prosecutions for violations of legislation on therapeutic products. The Agency may carry out penal investigations and may impose sanctions. More information...